Literature DB >> 33371439

TGFβ1 Suppressed Matrix Mineralization of Osteoblasts Differentiation by Regulating SMURF1-C/EBPβ-DKK1 Axis.

Bora Nam1,2, Hyosun Park1,3, Young Lim Lee1, Younseo Oh1, Jinsung Park1,3, So Yeon Kim1,3, Subin Weon1,3, Sung Hoon Choi4, Jae-Hyuk Yang5, Sungsin Jo1, Tae-Hwan Kim1,2,3.   

Abstract

Transforming growth factor β1 (TGFβ1) is a major mediator in the modulation of osteoblast differentiation. However, the underlying molecular mechanism is still not fully understood. Here, we show that TGFβ1 has a dual stage-dependent role in osteoblast differentiation; TGFβ1 induced matrix maturation but inhibited matrix mineralization. We discovered the underlying mechanism of the TGFβ1 inhibitory role in mineralization using human osteoprogenitors. In particular, the matrix mineralization-related genes of osteoblasts such as osteocalcin (OCN), Dickkopf 1 (DKK1), and CCAAT/enhancer-binding protein beta (C/EBPβ) were dramatically suppressed by TGFβ1 treatment. The suppressive effects of TGFβ1 were reversed with anti-TGFβ1 treatment. Mechanically, TGFβ1 decreased protein levels of C/EBPβ without changing mRNA levels and reduced both mRNA and protein levels of DKK1. The degradation of the C/EBPβ protein by TGFβ1 was dependent on the ubiquitin-proteasome pathway. TGFβ1 degraded the C/EBPβ protein by inducing the expression of the E3 ubiquitin ligase Smad ubiquitin regulatory factor 1 (SMURF1) at the transcript level, thereby reducing the C/EBPβ-DKK1 regulatory mechanism. Collectively, our findings suggest that TGFβ1 suppressed the matrix mineralization of osteoblast differentiation by regulating the SMURF1-C/EBPβ-DKK1 axis.

Entities:  

Keywords:  C/EBPβ; DKK1; SMURF1; TGFβ1; mineralization; osteoblast differentiation

Mesh:

Substances:

Year:  2020        PMID: 33371439      PMCID: PMC7767413          DOI: 10.3390/ijms21249771

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  53 in total

1.  Ubiquitin-mediated degradation a mechanism for fine-tuning TGF-beta signaling.

Authors:  M Datto; X-F Wang
Journal:  Cell       Date:  2005-04-08       Impact factor: 41.582

2.  Sequence analysis of the promoter region of the glioblastoma derived T cell suppressor factor/transforming growth factor (TGF)-beta 2 gene reveals striking differences to the TGF-beta 1 and -beta 3 genes.

Authors:  U Malipiero; M Höller; U Werner; A Fontana
Journal:  Biochem Biophys Res Commun       Date:  1990-09-28       Impact factor: 3.575

Review 3.  Dynamics of the transition from osteoblast to osteocyte.

Authors:  Sarah L Dallas; Lynda F Bonewald
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

Review 4.  Disorders of bone remodeling.

Authors:  Xu Feng; Jay M McDonald
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

5.  C/EBPβ binds the P1 promoter of the Runx2 gene and up-regulates Runx2 transcription in osteoblastic cells.

Authors:  Berta Henriquez; Matias Hepp; Paola Merino; Hugo Sepulveda; Andre J van Wijnen; Jane B Lian; Gary S Stein; Janet L Stein; Martin Montecino
Journal:  J Cell Physiol       Date:  2011-11       Impact factor: 6.384

6.  In vivo stimulation of bone formation by transforming growth factor-beta.

Authors:  M Noda; J J Camilliere
Journal:  Endocrinology       Date:  1989-06       Impact factor: 4.736

7.  Dickkopf1 destabilizes atherosclerotic plaques and promotes plaque formation by inducing apoptosis of endothelial cells through activation of ER stress.

Authors:  Mingxue Di; Lin Wang; Mengmeng Li; Yu Zhang; Xinxin Liu; Renya Zeng; Han Wang; Yifei Chen; Weijia Chen; Yun Zhang; Mei Zhang
Journal:  Cell Death Dis       Date:  2017-07-13       Impact factor: 8.469

8.  The Characteristics Of Human Bone-Derived Cells (HBDCS) during osteogenesis in vitro.

Authors:  Edyta Wrobel; Joanna Leszczynska; Edyta Brzoska
Journal:  Cell Mol Biol Lett       Date:  2016-11-16       Impact factor: 5.787

9.  TGF‑β1 promotes the osteoinduction of human osteoblasts via the PI3K/AKT/mTOR/S6K1 signalling pathway.

Authors:  Zhaodong Zhang; Xiuzhi Zhang; Dewei Zhao; Baoyi Liu; Benjie Wang; Weiting Yu; Junlei Li; Xiaobing Yu; Fang Cao; Guoshuang Zheng; Yao Zhang; Yupeng Liu
Journal:  Mol Med Rep       Date:  2019-03-18       Impact factor: 2.952

10.  SOCS1 suppresses IL-1β-induced C/EBPβ expression via transcriptional regulation in human chondrocytes.

Authors:  You-Jung Ha; Yong Seok Choi; Eun Ha Kang; Kichul Shin; Tae Kyun Kim; Yeong Wook Song; Yun Jong Lee
Journal:  Exp Mol Med       Date:  2016-06-24       Impact factor: 8.718

View more
  4 in total

Review 1.  NEDD4 E3 Ligases: Functions and Mechanisms in Bone and Tooth.

Authors:  Ke Xu; Yanhao Chu; Qin Liu; Wenguo Fan; Hongwen He; Fang Huang
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

Review 2.  E3 Ubiquitin Ligases: Potential Therapeutic Targets for Skeletal Pathology and Degeneration.

Authors:  Ruiyin Zeng; Yuan Xiong; Ze Lin; Adriana C Panayi; Yun Sun; Faqi Cao; Guohui Liu
Journal:  Stem Cells Int       Date:  2022-09-27       Impact factor: 5.131

3.  Effect of Muscle Cell Preservation on Viability and Differentiation of Hamstring Tendon Graft In Vitro.

Authors:  Jin Kyu Lee; Sungsin Jo; Young Lim Lee; Subin Weon; Jun-Seob Song; Il-Hoon Sung; Tae-Hwan Kim
Journal:  Cells       Date:  2021-03-27       Impact factor: 6.600

4.  BMP-2 Long-Term Stimulation of Human Pre-Osteoblasts Induces Osteogenic Differentiation and Promotes Transdifferentiation and Bone Remodeling Processes.

Authors:  Lena-Christin Ingwersen; Marcus Frank; Hendrik Naujokat; Klaas Loger; Rainer Bader; Anika Jonitz-Heincke
Journal:  Int J Mol Sci       Date:  2022-03-12       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.